CONTAK RENEWAL
Report
- Report Number
- 2124215-2011-12227
- Event Type
- Injury
- Date Received
- July 23, 2011
- Date of Event
- January 1, 2007
- Report Date
- June 13, 2011
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- NIK
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Narratives
UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, INTERROGATION REVEALED THAT THE DEVICE HAD REACHED ELECTIVE REPLACEMENT INDICATOR (ERI), END OF LIFE (EOL) AND STORAGE MODE. THE RESULTS OF A LONGEVITY CALCULATION INDICATED THAT THE MONITORING VOLTAGE WAS NORMAL BASED ON THERAPY USE AND PROGRAMMED SETTINGS. ALTHOUGH THE BATTERY ITSELF HAD NOT DEPLETED PREMATURELY, TWO CONSECUTIVE CHARGE TIMES IN EXCESS OF THE 18 SPECIFICATION TRIGGERED ERI EARLIER THAN EXPECTED. DEVICE CIRCUITRY WAS DESIGNED SUCH THAT THE ERI CHARGE TIME LIMIT OF 18 SECONDS WOULD BE REACHED NEAR THE CORRESPONDING ERI MONITORING VOLTAGE LIMIT. ENGINEERS CONCLUDED THAT THIS DEVICE DID NOT EXPERIENCE A COMPONENT FAILURE OR PREMATURE BATTERY DEPLETION. RATHER, THE REPLACEMENT INDICATOR WAS DECLARED DUE TO A BUILD-UP OF INTERNAL BATTERY IMPEDANCE, PREVENTING THE DEVICE FROM MEETING ITS EXPECTED LONGEVITY PER DEVICE LABELING.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS DEVICE DECLARED END OF LIFE (EOL) AND REMAINED IN THAT STATUS FOR APPROXIMATELY FOUR YEARS. THE DEVICE WAS CURRENTLY IN STORAGE MODE, WITH A BATTERY VOLTAGE OF 1.76 VOLTS. THE PATIENT IMPLANTED WITH THIS DEVICE WAS IN A STATE OF PARTIAL DO NOT RESUSCITATE (DNR) AND EXPERIENCED A SYNCOPAL EPISODE. THE PHYSICIAN ELECTED TO EXPLANT THIS DEVICE AND REPLACE WITH A BI-VENTRICULAR PACEMAKER. NO ADVERSE PATIENT EFFECTS WERE REPORTED DURING THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | CONTAK RENEWAL | IMPLANTABLE CHF GENERATOR | NIK | GUIDANT CRM CLONMEL IRELAND | H135 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 80 YR | Hospitalization| L| R | 4513| 1821| H135| 0125| 4269 |